Int J Biol Sci 2020; 16(13):2392-2404. doi:10.7150/ijbs.47035 This issue Cite

Research Paper

LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma

Xinyu Wang1*, Yue Zhao1*, Xiang Fei1*, Qijue Lu1, Yang Li2, Yang Yuan2, Chaojing Lu1✉, Chunguang Li1✉, Hezhong Chen1✉

1. Department of Thoracic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China;
2. Department of Cardiovascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
*Authors contributed equally to this manuscript.

Citation:
Wang X, Zhao Y, Fei X, Lu Q, Li Y, Yuan Y, Lu C, Li C, Chen H. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. Int J Biol Sci 2020; 16(13):2392-2404. doi:10.7150/ijbs.47035. https://www.ijbs.com/v16p2392.htm
Other styles

File import instruction

Abstract

Graphic abstract

Our previous study demonstrated that lymphoid enhancer-binding factor 1 (LEF1) could promote the progression of esophageal squamous cell carcinoma (ESCC). However, the regulatory mechanism of LEF1 was not clear thoroughly. Herein, we continued to explore the downstream mechanism of LEF1 in ESCC. In this study, we applied western blotting, quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry, RNA-Seq analysis, a luciferase reporter assay, chromatin immunoprecipitation (ChIP), bioinformatics analysis, and a series of functional assays in vitro and in vivo. The results demonstrated that LEF1 regulated directly the expression of Id3. Id3 was highly expressed in ESCC tissues and correlated with histologic differentiation (p=0.011), pT stage (p<0.01) and AJCC stage (p<0.01) in ESCC patients. Moreover, Id3 could serve as a prognostic factor of ESCC. By various functional experiments, overexpression of Id3 promoted the proliferation, migration, invasion, EMT, and tumorgenicity. Mechanistically, Id3 could regulate ERK/MAPK signaling pathway via activating HRAS to perform its biological function. Furthermore, activating ERK/MAPK signaling pathway promoted the expression of Id3 gene in turn, indicating that a positive regulatory loop between Id3 and ERK/MAPK pathway may exist in ESCC. In summary, LEF1/Id3/HRAS axis could promote the tumorigenesis and progression of ESCC via activating ERK/MAPK signaling pathway. Targeting this cascade may provide a valid antitumor strategy to delay ESCC progress.

Keywords: LEF1, Id3, HRAS, esophageal squamous cell carcinoma, MAPK signaling pathway.


Citation styles

APA
Wang, X., Zhao, Y., Fei, X., Lu, Q., Li, Y., Yuan, Y., Lu, C., Li, C., Chen, H. (2020). LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. International Journal of Biological Sciences, 16(13), 2392-2404. https://doi.org/10.7150/ijbs.47035.

ACS
Wang, X.; Zhao, Y.; Fei, X.; Lu, Q.; Li, Y.; Yuan, Y.; Lu, C.; Li, C.; Chen, H. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. Int. J. Biol. Sci. 2020, 16 (13), 2392-2404. DOI: 10.7150/ijbs.47035.

NLM
Wang X, Zhao Y, Fei X, Lu Q, Li Y, Yuan Y, Lu C, Li C, Chen H. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. Int J Biol Sci 2020; 16(13):2392-2404. doi:10.7150/ijbs.47035. https://www.ijbs.com/v16p2392.htm

CSE
Wang X, Zhao Y, Fei X, Lu Q, Li Y, Yuan Y, Lu C, Li C, Chen H. 2020. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma. Int J Biol Sci. 16(13):2392-2404.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image